Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Hematologic Oncology

Breast Cancer

Gastrointestinal Cancer

Hematologic Oncology

Genomic Breakthroughs Offer Hope for New Strategies in AML

Hetty Carraway, MD, highlights ongoing genomic research in acute myeloid leukemia, as well as recent therapeutic advances in the field.
Read More >>

Expert Breaks Down Diagnosis and Treatment of Classical MPNs

Japanese Approval Sought for Quizartinib in FLT3-ITD+ AML

Expert Highlights FLT3 Inhibitors in AML

Emerging Agents Offer Hope in Late Relapse Myeloma

SOSS HEM CLEVELAND 2018: Targeted Agents Beyond Ruxolitinib Necessary in Evolving MPN Paradigm

View More Stories >>

View Conference Coverage

2018 State of the Science Summit on Hematologic Malignancies in Clayton

State of the Science Summit on GI Cancers in Newport Beach

2018 ESMO Congress

2018 State of the Science Summit on Hematologic Malignancies in Cleveland

2018 Lynn Sage Breast Cancer Symposium

Dr. Damon on Drug Development in AML

Dr. Fakhri on the Use of Carfilzomib in Multiple Myeloma

Dr. Martin on Autologous Stem Cell Transplant in Multiple Myeloma

Dr. Radich on Compliance to NCCN Guidelines in CML

Dr. Verstovsek on Accelerated Phase Myelofibrosis

Dr. Wong on a Trial With an Anti-CD46 Antibody in Myeloma

Dr. Shah Discusses Frontline Considerations for the Treatment of CML

OncLive houses thousands of videos that provide updates and information.
See more Videos

Multiple Myeloma: Closing Considerations for Treatment

Addressing Treatment of Myeloma-Related Comorbidity

Venetoclax: Potential Use in Multiple Myeloma

$Considering Selinexor in Penta-Refractory Myeloma$

Optimizing the Use of Anti-BCMA Therapy in MM

Unmet Needs and Future Directions in CML

TFR With Nilotinib in CML: ENESTfreedom and ENESTop

OncLive houses thousands of videos that provide updates and information.
See more Videos

Future Treatment Approaches to AML

Moving the AML Treatment Landscape Forward

Optimizing the Use of FLT3 Inhibitor Therapy for AML

Long-Term Challenges With FLT3 Inhibition in AML

Testing for FLT3 Mutations in the Community Setting of AML

Quizartinib's Potential Role in Treating AML

Personal Experience Managing AML With Quizartinib

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Therapeutic Inhibition of XPO1-Mediated Nucleocytoplasmic Transport With SINE Technology

Cancer is a complex disease characterized by uncontrolled cell growth and metastatic dissemination of tumor cells. View Now

Dr. Ramchandren on the North American Results of the ECHELON-1 Study in Hodgkin Lymphoma

Radhakrishnan Ramchandren MD, associate professor, Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute, discusses the North American results of the ECHELON-1 study in Hodgkin lymphoma. View Now

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

OncLive News Network On Location: 2018 ESMO Congress